Birgit Girshick, Chief Executive Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 6,500 shares at $279.90 ($1.8M) on 2026-08-11, disclosed to the SEC on 2026-08-13.
Scheduled sale ($1.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRL | SELL | 2023-02-17 | $1.5M | — | Filing → |
| CRL | SELL | 2021-09-15 | $2.1M | — | Filing → |
| CRL | SELL | 2021-04-07 | $9.6M | — | Filing → |